Skip to main content
Equibles

Legato Capital Management LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1442641 San Francisco, CA
Back to OCUL Full portfolio

Position in OCUL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,585,537
+$552,613 QoQ
Shares Held
161,460
+32.4% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legato Capital Management LLC holds $78,908,724 across 38 Biotechnology names. OCUL ranks #19 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 58,512 $6,849,999
2 RVMD
Revolution Medicines, Inc.
 33,042 $6,188,105
3 TVTX
Travere Therapeutics, Inc.
 87,833 $4,989,792
4 LGND
Ligand Pharmaceuticals Inc
 15,569 $4,921,205
5 AXSM
Axsome Therapeutics, Inc.
 18,644 $4,563,491
6 PVLA
Palvella Therapeutics, Inc.
 23,490 $3,589,741
7 CORT
Corcept Therapeutics Inc
 41,186 $3,581,122
8 ELVN
Enliven Therapeutics, Inc.
 64,769 $3,287,026

All Filings in OCUL

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,585,537 161,460
2026-03-31 $1,032,924 121,951
2025-12-31 $1,501,098 123,649
2025-09-30 $1,318,865 112,820
2025-06-30 $1,046,969 112,820
2025-03-31 $828,949 113,090
2024-12-31 $980,562 114,820
2024-09-30 $1,300,780 149,515
2024-06-30 $1,022,682 149,515
2024-03-31 $1,360,586 149,515
2023-12-31 $666,836 149,515
2023-06-30 $600,567 116,389